|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-11-28
|
|
pubmed:abstractText |
Thymic carcinoma is a rare mediastinal neoplasm with poor prognosis. Although the clinical benefit of chemotherapy for thymic carcinoma is controversial, cisplatin-based chemotherapy with or without radiation therapy is ordinarily adopted in advanced cases. We evaluated the clinical outcome of platinum-based chemotherapy with or without radiation therapy in unresectable thymic carcinoma patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
385-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11095135-Adult,
pubmed-meshheading:11095135-Aged,
pubmed-meshheading:11095135-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11095135-Carcinoma,
pubmed-meshheading:11095135-Carcinoma, Squamous Cell,
pubmed-meshheading:11095135-Cisplatin,
pubmed-meshheading:11095135-Female,
pubmed-meshheading:11095135-Humans,
pubmed-meshheading:11095135-Male,
pubmed-meshheading:11095135-Middle Aged,
pubmed-meshheading:11095135-Survival Analysis,
pubmed-meshheading:11095135-Thorax,
pubmed-meshheading:11095135-Thymus Neoplasms
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma.
|
|
pubmed:affiliation |
Thoracic Oncology Division, National Cancer Center Hospital, Tokyo, Japan. nmmc2@bronze.ocn.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
